MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Apyx Medical Corporation DSO Ratio 2011-2026 | APYX
Annual DSO Ratio Apyx Medical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111 | 112 | 85.8 | 96.9 | 80.6 | 228 | 119 | 110 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 228 | 80.6 | 118 |
Quarterly DSO Ratio Apyx Medical Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85.9 | 91.8 | 131 | - | 102 | - | - | - | - | - | 77.3 | - | 97.3 | 101 | 92.8 | - | 78.8 | 67.8 | 245 K | - | 76.6 K | 109 K | 3.46 K | 87 | 2.23 K | 1.81 K | 1.41 K | 77.7 | 3.39 K | - | - | 121 | 167 | 45.2 | 52.2 | 45.5 | 42.9 | 46.5 | 44.9 | 32.2 | 34.1 | 36.7 | 36.6 | 24.4 | 26.8 | 26.2 | 28 | 29.6 | 31.3 | 30.1 | 39 | 38.4 | 39.3 | 35.2 | 34.5 | 32.8 | 32.3 | 29.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 245 K | 24.4 | 9.47 K |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.2 | -0.9 % | $ 3.43 M |  USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 10.62 | 1.63 % | $ 1.44 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 12.9 | -1.15 % | $ 1.94 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 9.73 | -12.81 % | $ 276 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 8.37 | 0.06 % | $ 601 M |  Israel |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 4.09 | -4.11 % | $ 866 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.65 | -4.4 % | $ 35.4 M | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 71.54 | 0.41 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.92 | -3.21 % | $ 146 M |  France |
 |
CONMED Corporation
CNMD
|
64.5 | $ 37.23 | 0.13 % | $ 1.16 B | USA |
 |
Establishment Labs Holdings
ESTA
|
123 | $ 65.34 | 0.51 % | $ 1.94 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.55 | -0.73 % | $ 876 M | Israel |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
237 | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
61.2 | $ 108.57 | -1.97 % | $ 189 B | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.33 | - | $ 21.5 M | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 9.53 | -2.16 % | $ 341 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 269.91 | 0.2 % | $ 7.62 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.79 | -2.44 % | $ 394 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 2.09 | -3.92 % | $ 1.27 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 31.05 | -5.19 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
86.7 | $ 172.96 | -1.79 % | $ 13 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 8.91 | -2.09 % | $ 686 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 34.46 | 2.13 % | $ 5.14 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
69.7 | $ 0.42 | 8.36 % | $ 43.2 M | USA |
 |
IRadimed Corporation
IRMD
|
52.7 | $ 101.38 | -1.39 % | $ 1.29 B | USA |